150 research outputs found

    Development and genetics of maize doubled haploid lines

    Get PDF
    The present study was carried out to develop doubled haploid lines using in-vivo maternal haploid induction technique.The study was aimed at the reliability of haploid seed identification through the R1-nj visual colored marker,identification of spontaneous doubling in tropical germplasm, optimization of colchicine percentage and seedlingcutting methods for artificial chromosome doubling and revealing the genetics of newly developed DH-lines. Twotropical haploid inducer lines with 4-6% HIR were used as male parents and crossed with a single hybrid FH-949as female donor parent. The R1-nj visual colored marker was used to sort haploid from diploid kernels. To checkthe spontaneous chromosome doubling rate these haploid kernels were grown in the field. In the laboratory, differentcolchicine percentages and seedling cutting treatments were used to double these maternal haploids. Thedata for seedling survival and DHo seed formation was collected and generalized linear model GLM was used tointerpret treatment results. SAS 9.2 was used to estimate confidence intervals for the binomial proportion havingzero frequencies. Out of twenty doubled haploid lines developed, five were crossed with three OPVs in line ×tester mating design. The data was collected and evaluated for combining ability and type of gene action for theyield and its related traits. The R1-nj dominant anthocyanin marker was found to be 91 percent effective in identifyingmaternal haploid seeds at the dormant stage. The spontaneous doubling percentage of maternal haploidswas recorded 0.8%. All the lines showed good general combining ability. The additive type of gene action wasprevailing in most of the traits studied

    Recompensa, um motorista para a criatividade; papel mediador das avaliações de recompensa entre auto eficácia e desempenho criativo

    Get PDF
    The purpose of this dyadic study was to explore the insight that trigger the creative performance. For such purpose self-efficacy and rewards in shape of challenge and threat appraisal were used. A Survey was conducted to collect the data from the public and private sector organizations related to technical education in Punjab. Sample was the faculty member working on positions of instructors, senior instructor and lectures. A total of 302 respondents were analyzed. The results of the analysis show that there is significant relationship among self-efficacy and creative performance. The mediation analysis also shows that challenge appraisal of rewards for creativity and threat appraisal of reward also worked as mediator. Consequently, we reached at the point that having high level of self-efficacy, individuals in technical education organizations appraises the reward as a challenge and perform creatively. And on the other side having low level of self-efficacy, but appraising the Reward as a threat, tends to impact negatively on creative performance.El propósito de este estudio diádico fue explorar la información que desencadena el rendimiento creativo. Para tal fin se utilizaron la autoeficacia y las recompensas en forma de desafío y evaluación de amenazas. Se realizó una encuesta para recopilar los datos de las organizaciones del sector público y privado relacionadas con la educación técnica en Punjab. La muestra fue el miembro de la facultad que trabaja en posiciones de instructores, instructor senior y conferencias. Se analizaron un total de 302 encuestados. Los resultados del análisis muestran que existe una relación significativa entre la autoeficacia y el rendimiento creativo. El análisis de la mediación también muestra que la evaluación desafiante de las recompensas por la creatividad y la evaluación de la amenaza de recompensa también funcionó como mediador. En consecuencia, llegamos al punto en que, al tener un alto nivel de autoeficacia, los individuos en las organizaciones de educación técnica valoran la recompensa como un desafío y se desempeñan de manera creativa. Por otro lado, tiene un bajo nivel de autoeficacia, pero evaluar la recompensa como una amenaza, tiende a tener un impacto negativo en el rendimiento creativo.O objetivo deste estudo diádico foi explorar a percepção que aciona o desempenho criativo. Para esse propósito, a auto-eficácia e as recompensas em forma de desafio e avaliação de ameaça foram usadas. Uma pesquisa foi realizada para coletar os dados das organizações do setor público e privado relacionadas à educação técnica em Punjab. Amostra foi o membro do corpo docente trabalhando em posições de instrutores, instrutor sênior e palestras. Um total de 302 respondentes foi analisado. Os resultados da análise mostram que existe uma relação significativa entre autoeficácia e desempenho criativo. A análise da mediação também mostra que a avaliação de recompensas de recompensas por criatividade e avaliação de ameaças de recompensa também funcionou como mediador. Consequentemente, chegamos ao ponto em que, tendo alto nível de autoeficácia, indivíduos em organizações de educação técnica avaliam a recompensa como um desafio e realizam de forma criativa. Por outro lado, ter baixo nível de autoeficácia, mas avaliar a recompensa como uma ameaça, tende a impactar negativamente no desempenho criativo

    The impact of the ‘hub and spoke’ model of care for lung cancer and equitable access to surgery

    Get PDF
    Objectives: To determine the influence of where a patient is first seen (either surgical or non-surgical centre) and patient features on having surgery for non-small cell lung cancer (NSCLC). Design: Cross-sectional study from individual patients, between 1January 2008 and 31March 2012. Setting: Linked National Lung Cancer Audit and Hospital Episode Statistics datasets. Participants: 95 818 English patients with a diagnosis of NSCLC, of whom 12 759 (13%) underwent surgical resection. Main outcome measure: Odds of having surgery based on the empirical catchment population of the 30 thoracic surgical centres in England and whether the patient is first seen in a surgical centre or a non-surgical centre. Results: Patients were more likely to be operated on if they were first seen at a surgical centre (OR 1.37; 95% CI 1.29 to 1.45). This was most marked for surgical centres with the largest catchment populations. In these surgical centres with large catchment populations, the resection rate for local patients was 18% and for patients first seen in a non-surgical centre within catchment was 12%. Conclusions: Surgical centres that serve the largest catchment populations have high resection rates for patients first seen in their own centre but, in contrast, low resection rates for patients first seen at the surrounding centres they serve. Our findings demonstrate the importance of going further than relating resection rates to hospital volume or surgeon number, and show that there is a pressing need to design lung cancer services which enable all patients, including those first seen at non-surgical centres, to have equal access to lung cancer surgery

    Which patients are assessed by lung cancer nurse specialists? A national lung cancer audit study of over 128,000 patients across England

    Get PDF
    Background: Lung cancer nurse specialists (LCNS) are integral to the multidisciplinary clinical team, providing personalised physical and psycho-social interventions, and care management for people with lung cancer. The National Institute of Health and Care Excellence (NICE) recommend that all patients have access to a LCNS. We conducted a national study assessing whether there is variation in access to and timing of LCNS assessment. Methods: The National Cancer Action Team’s LCNS workforce census in England was linked with patient and hospital Trust data from the English National Lung Cancer Audit. Multivariate logistic regression was used to assess features associated with LCNS assessment. Results: 128,124 lung cancer patients were seen from 2007 to 2011. LCNS assessment confirmation was ‘yes’ in 62%, ‘no’ in 6% and ‘missing’ in 32%. Where (in clinic versus ward) and when (before versus after diagnosis) patients were assessed by a LCNS also varied. Older patients with poor performance status, early cancer stage, and comorbidities were less likely to be assessed; there was no difference with sex or socioeconomic group. Patients receiving any anti-cancer treatment were more likely to be assessed. Assessment was lower in Trusts with high annual patient numbers (odds ratio = 0.58, 95% confidence interval 0.37–0.91) and where LCNS caseload > 250 (0.69, 0.41–1.16, although not statistically significant), but increased where workload was conducted mostly by band 8 nurses (2.22, 1.22–4.02). Conclusion: LCNS assessment varied by patient and Trust features, which may indicate unmet need for some patients. The current workforce needs to expand as well as retain experienced LCNSs

    Factors influencing treatment selection and thirty-day mortality following chemotherapy for people with small cell lung cancer: an analysis of national audit data

    Get PDF
    Background Thirty-day mortality after treatment for lung cancer is a measure of unsuccessful outcome and where treatment should have been avoided. Guidelines recommend offering chemotherapy to individuals with small cell lung cancer (SCLC) who have poorer performance status (PS) because of its high initial response rate. However, this comes with an increased risk of toxicity and early death. We quantified real-world 30-day mortality in SCLC following chemotherapy, established the factors associated with this and compared these to the factors that influence receipt of chemotherapy. Methods We used linked national English datasets to define the factors associated with both receiving chemotherapy and 30-day mortality following chemotherapy. Results We identified 3,715 people diagnosed with SCLC, of which 2,235 (60.2%) received chemotherapy. There were 174 (7.8%) deaths within 30 days of chemotherapy. The adjusted odds of receiving chemotherapy decreased with older age, worsening PS and increasing comorbidities. Thirty-day mortality was independently associated with poor PS (PS 2 vs PS 0 adjusted OR 3.75 95% CI 1.71-8.25) and stage (extensive vs limited adjusted OR 1.68 95% CI 1.03-2.74) but in contrast was not associated with increasing age. Both chemotherapy administration and 30-day mortality varied by hospital network.Conclusions To reduce variation in chemotherapy administration predictors of 30-day mortality could be used as an adjunct to improve sub-optimal patient selection. We have quantified 30-day mortality risk by the two independently associated factors, PS and stage, so that patients and clinicians can make better informed decisions about the potential risk of early death following chemotherapy

    Do working practices of cancer nurse specialists improve clinical outcomes? Retrospective cohort analysis from the English National Lung Cancer Audit

    Get PDF
    Background Cancer nurse specialists are advanced practitioners who offer continuity of care and expert support for people diagnosed with specific cancers. Health Education England's Cancer Workforce Plan prioritises expansion of cancer nurse specialist numbers by 2021 as part of the Cancer Taskforce Strategy for England. Objective To assess whether working practices of advanced practice specialist nurses are associated with clinical outcomes for people with lung cancer. Methods Adults with non-small cell lung cancer followed from 30 days post-diagnosis in English secondary care were obtained from the English National Lung Cancer Audit, 2007 to 2011. A national survey of lung cancer nurse specialists provided information on self-reported working practices. Mortality and unplanned admissions from 30 days to 12 months post diagnosis were respectively analysed using Cox and Poisson regression. Outcomes were assessed according to patients’ receipt of initial assessments by a lung cancer nurse specialist and according to trust-level reported working practices. Regression models were adjusted for individual sociodemographic and clinical characteristics, error adjusted for intracorrelations within regional cancer networks, and presented separately according to patients’ treatment pathways (surgery, chemotherapy, radiotherapy, or no anti-cancer therapy). Results Data for 108,115 people with lung cancer were analysed and associations with mortality and unplanned admissions were infrequent. Among people receiving only radiotherapy, however, the hazard for death was 17% lower among those who received an assessment by a lung cancer nurse specialist, compared with no assessment (hazard ratio = 0.83, 95% confidence interval 0.73–0.94; p = 0.003). The hazard was also lower among those receiving surgery (hazard ratio = 0.91, 0.84–0.99; p = 0.028). Among those receiving radiotherapy, nurse specialists’ reported confidence within multidisciplinary team settings was associated with a lower risk of death (hazard ratio = 0.88, 0.78–1.00; p = 0.049) and a lower rate of unplanned cancer-related admissions (incidence rate ratio = 0.83, 0.73–0.95; p = 0.007). Lung cancer nurse specialist assessments before/at diagnosis, were associated with a 5% lower rate of unplanned admissions, compared to when assessments occurred after diagnosis. Conclusion The contribution of nurse specialist working practices was occasionally associated with better outcomes for people with lung cancer. These were not limited to a single treatment pathway, but do indicate discrete relationships within pathways. Our study provides initial measures of overall lung cancer nurse specialist working practices at trusts, however, more detailed studies with longitudinal measurement of lung cancer nurse specialist-patient interaction are needed to better ascertain impacts on long-term patient outcomes. The findings highlight opportunities for potential improvement in effectiveness of service and care management
    • …
    corecore